共 10 条
[1]
[2]
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy[J] AIDS 2008,
[3]
Entecavir Therapy for Adefovir-Resistant Hepatitis B Virus Infection in Kidney and Liver Allograft Recipients[J] Nassim Kamar;Olivier Milioto;Laurent Alric;Labib El Kahwaji;Olivier Cointault;Laurence Lavayssière;Karine Sauné;Jacques Izopet;Lionel Rostaing Transplantation 2008,
[4]
Virologic; serologic; and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-na?ve Chinese patients with chronic hepatitis B: a randomized; multicenter study[J] Guangbi Yao;ChengWei Chen;WeiLun Lu;Hong Ren;DeMing Tan;YuMing Wang;DaoZheng Xu;Jessica Liu;Dong Xu;Cyril Llamoso Hepatology International 2008,
[5]
OL-016 Adefovir plus entecavir or plus lamivudine as rescue therapies for chronic hepatitis B patients who develop resistance to entecavir[J] S. Yang;R.X. Xue;Q. Wang;H.C. Xing;J. Guo;W. Xie;J. Yan;J. Cheng International Journal of Infectious Diseases 2008,
[6]
703 LONG TERM EFFICACY; SAFETY AND RESISTANCE ANALYSES OF ENTECAVIR (ETV) TREATMENT IN JAPANESE NUCLEOSIDE-NAIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB)[J] S. Mochida;K. Takaguchi;O. Yokosuka;S. Fujioka;N. Hayashi;M. Shindo;K. Chayama;J. Toyota;H. Ishikawa;T. Seriu;O. Omata Journal of Hepatology 2008,
[7]
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update[J] Yun-Fan Liaw;Nancy Leung;Jia-Horng Kao;Teerha Piratvisuth;Edward Gane;Kwang-Hyub Han;Richard Guan;George K. K. Lau;Stephen Locarnini Hepatology International 2008,
[8]
Entecavir for Treatment of Lamivudine-Refractory; HBeAg-Positive Chronic Hepatitis B[J] Morris Sherman;Cihan Yurdaydin;Jose Sollano;Marcelo Silva;Yun–Fan Liaw;Janusz Cianciara;Anna Boron–Kaczmarska;Paul Martin;Zachary Goodman;Richard Colonno;Anne Cross;Gail Denisky;Bruce Kreter;Robert Hindes Gastroenterology 2006,
[9]
45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(?) chronic hepatitis B patients (study ETV-027)[J] D. Shouval;U.S. Akarca;G. Hatzis;G. Kitis;C.L. Lai;H. Cheinquer;T.T. Chang;R. Zink;J. Zhu;H. Brett-Smith Journal of Hepatology 2006,
[10]
Three years of entecavir(ETV)re-treatment of HBeAg(-)patients who previously discon-tinued ETV treatment:results from study ETV-901 Shouval D;Lai CL;Chang TT;et al; Hepatology 2008,